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Gy in 28 fractions. Plans were evaluated based on the ability 
to meet the dose volume histogram. The homogeneity index 
(HI), conformity index (CI) of target volume, the dose of 
organs at risk, radiation delivery time and monitor units were 
also compared. Paired T-test model analysis was used to 
analyse the two sets of data.  
 
Results: The results showing that postoperative endometrial 
carcinoma can be implemented CDR-CAS-IMAT plans on 
conventional Varian 23EX Linac for smoothly and quickly at 
busy cancer center. Comparing with the IMRT techonology 
CDR-CAS-IMAT plans can meet the clinical demand(see 
Figure1), gives comparable OAR and improved CI of PTV (see. 
Table 1), can reduction treatment time ((84.6±7.8)s Vs. 
(422.7±46.7)s), MU((787.5±78.5)MU Vs.(927.4±79.1)MU) and 
high dose irradiated volume; while increase the low dose 
irradiated volume of healthy tissues and the volume of the 
bladder and bowel irradiated 40 Gy and 30Gy, respectively. 
This point needs to pay attention to implementation in 
clinical. There were no significant differences in other 







Conclusion: Endometrial carcinoma patients with CDR-CAS-
IMAT on Varian Clinical 23IX can get equivalent or superior 
dose distribution compared with the IMRT technology. CDR-
CAS-IMAT have much less treatment time and MU can reduce 
the uncertainty factor and patient discomfort in treatment.  
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Purpose or Objective: Aim of this study was to determine 
the dosimetric impact of flatting filter free beam (FFFB) of 6 
and 10 MV energies on rapid-arc (RA) radiotherapy planning 
for gynecological malignancies. 
 
Material and Methods: RA plans were generated using double 
arc for a cohort of ten patients using 6 and 10 MV FFFB. Plans 
were generated to deliver a dose of 50.4 Gy in 28 fractions 
for Planning target volume (PTV) and ALARA were used as an 
objective for Organs at risk (OARs). Plans were analysed for 
PTV Coverage, conformity Index (CI), homogeneity index (HI), 
dose to OAR’s, integral dose to normal tissue (NTID) and total 
no. of monitor units (MUs).  
 
Results: The volume of PTV receiving prescription dose were 
95.03+ 0.09% and 95.09+ 0.10%, HI were 1.062+ 0.008 and 
1.066+ 0.008,CI were 1.007+ 0.016 and 1.012+ 0.013, mean 
NTID were 272.2+ 37.1 and 261.1+ 33.2 (liter-Gy), MUs 
number were 629.6+ 31 and 647.2+ 44 for FFFB using 6 and 10 
MV respectively. There were no statistically significant 
(p>0.05) difference found in mean doses to bladder, rectum, 
bowel and both femoral heads for FFFB using 6 and 10 MV 
respectively. There were significant ( p <0.05) difference 
found in HI, MU number and NTID for FFFB using 6 and 10 MV 
respectively.  
 
Conclusion: FFFB of 6MV was found superior in comparison to 
10MV for RA planning in case of gynecological malignancies. 
It offers better HI, CI, less number of MUs (2.8%) and delivers 
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Purpose or Objective: The purpose of this study is to 
investigate the treatment plan dosimetry and delivery 
efficiency between the single-arc and double-arc techniques 
using stereotactic body radiotherapy with flattening filter 
free beams for early-stage lung cancer. 
 
Material and Methods: Nineteen patients were included in 
this investigation, and each patient was arranged single-
partial-arc (SA) and double-partial-arc (DA) techniques using 
the Eclipse 10.0 treatment planning system. The prescription 
dose was 48Gy/4 fractions and the photon beam energy was 6 
MV flattening filter-free (FFF) beams from Truebeam linear 
accelerator. The treatment plans were appraised by 
Radiation Therapy Oncology Group (RTOG-0915) criteria for 
planning target volume (PTV) coverage and organs at risk 
(OAR) sparing. All plans were normalized to 100% of 
prescribed dose at least covering 95% of the PTV. Treatment 
efficiency was evaluated via monitor units (MUs) and 
treatment times were compared. 
 
Results: The PTV volumes range from 20.46 to 88.37 cm3. 
Compared to the SA and DA plans, there was no significant 
difference in PTV coverage, except the maximum dose in the 
PTV. The maximum dose of SA technique was slightly higher 
than that of DA technique. The mean PTV conformity index 
(CI) for SA and DA was 1.06±0.05 and 1.01±0.03 respectively. 
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The mean PTV homogeneity index (HI) was 0.14±0.04 for SA 
and 0.09±0.03 for DA. For the OAR sparing, there was no 
significant difference between the SA and DA. A significantly 
difference was observed in the number of MUs and the 
treatment time, SA presents a reduction of 10.3% and 24.5% 
respectively. 
 
Conclusion: SA showed no significantly difference in PTV 
coverage and OAR sparing compared with DA, however, the 
CI and HI of DA were better than those of SA. SA improved 
the greater treatment efficiency, and achieved less MUs 
number. In order to reduce patient treatment time, SA is 
worth to consider. 
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Purpose or Objective: The modulated arc (mARC) is a VMAT-
like rotational technique specifically designed for “burst 
mode” delivery of high dose rates. Only few studies have 
assessed the performance of this radiotherapy modality, and 
it is unclear how efficient it will prove for target volumes of 
high vs. low complexity. We therefore present a planning and 
delivery study for two frequent clinical applications: a 
relatively simple target volume for prostate cancer without 
lymph node involvement and a highly complex target volume 
for hypopharynx cancer. In each case, plan quality, 
treatment time and scattered dose are compared for mARC 
vs. IMRT using flat or flattening-filter-free (FFF) beams. 
 
Material and Methods: Contours were retrospectively 
created for 10 prostate cancer patients and 8 head-and-neck 
cancer patients treated at our clinic. IMRT plans were set up 
using 11 beams and 55 segments. mARC plans for both 
energies were made using one rotation for prostate and two 
rotations for head-and-neck patients, with 4° arclets of 
spaced equidistantly every 8°. The Varian Eclipse treatment 
planning system with the AAA dose algorithm and a 2.5 mm 
dose grid was used for all plans. Plan quality was assessed 
using PTV coverage and sparing of organs at risk. All plans 
were delivered on an anthropomorphic phantom, where 
scattered dose was measured with thermoluminescent 
dosimeters (TLDs), and treatment times were recorded. 
 
Results: All plans were visually assessed by a senior radiation 
oncologist and were deemed acceptable for treatment. Only 
few significant differences were found for PTV coverage and 
OAR sparing. For prostate cancer plans, no significant 
differences in OAR sparing were found except for the 
bladder, which was better spared by mARC than IMRT for 
both beam energies. For head-and-neck cancer cases, the 
mARC technique achieved a higher index of conformity and 




While differences in plan quality were minor, treatment 
times could be drastically reduced by the combination of 
mARC with FFF beams.e average treatment times for 
prostate cancer were reduced from 7 min for 6 MV IMRT to 2-
3 min for FFF mARC. For the complex head-and-neck target 
volume, times were again reduced from ca. 9 min (IMRT, 6 
MV) to 5:30 min (mARC, FFF 7 MV), even though FFF 7 MV 
required significantly more monitor units than 6 MV plans.  
The scattered dose was considerably lower for the mARC as 
compared with IMRT for all plans. For the prostate, scattered 
dose was further reduced by the FFF beam energy. For 
hypopharynx cancer, this effect was partially obscured by the 
higher monitor units. 
 
 
Conclusion: Target volumes of high and of low complexity 
were analysed in this work. For both scenarios, the mARC 
technique achieved plan qualities comparable or even better 
than for IMRT, with a considerable reduction in treatment 
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Purpose or Objective: To investigate the feasibility of 
hippocampal-sparing radiotherapy for glioblastoma patients 
using volumetric modulated arc therapy (VMAT). Since 
neurocognitive decline has been associated with hippocampal 
dose, hippocampal sparing could potentially improve 
neurological outcome of patients undergoing cranial 
irradiation. 
 
Material and Methods: Datasets of 27 patients who received 
3D-CRT for glioblastoma were included in this planning study. 
Dose distributions for the 3D-CRT plans were calculated in 
Elekta Oncentra Masterplan with a pencil beam algorithm. 
VMAT plans were optimized using the research TPS Hyperion 
V2.44 (equivalent to Elekta Monaco 5.1) which relies on 
Monte Carlo dose calculation. It was attempted to reduce the 
dose to the contralateral hippocampus as much as possible 
without compromising other treatment parameters such as 
target coverage, homogeneity index, conformity index and 
dose to other organs at risk including brain stem, chiasm, 
optic nerve and lenses. Parameters for both techniques were 
compared applying the Wilcoxon signed-rank test. The 
influence of tumor localization on hippocampal dose 
exposure was investigated with the Mann-Whitney U test. The 
correlation between PTV size and hippocampal dose was 
assessed with Spearman’s rank correlation coefficient. 
 
Results: With VMAT compared to 3D-CRT, the median 
reduction of the mean contralateral hippocampus dose was 
56% (p<0.01). Other treatment parameters could be improved 
or at least be kept stable. Particularly, the median V30Gy of 
the brain was reduced from 58.7% to 48.2% (p<0.01). The 
median homogeneity index improved from 0.18 for 3D-CRT to 
0.15 for VMAT (p<0.01), the median conformity index from 
0.70 to 0.80 (p<0.01). For VMAT, a smaller PTV size 
correlated with improved hippocampal sparing (p=0.01). A 
